GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yunnan Biovalley Pharmaceutical Co Ltd (BJSE:833266) » Definitions » Margin of Safety % (DCF Earnings Based)

Yunnan Biovalley Pharmaceutical Co (BJSE:833266) Margin of Safety % (DCF Earnings Based) : N/A (As of May. 13, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Yunnan Biovalley Pharmaceutical Co Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Yunnan Biovalley Pharmaceutical Co's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

Competitive Comparison of Yunnan Biovalley Pharmaceutical Co's Margin of Safety % (DCF Earnings Based)

For the Drug Manufacturers - Specialty & Generic subindustry, Yunnan Biovalley Pharmaceutical Co's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Yunnan Biovalley Pharmaceutical Co's Margin of Safety % (DCF Earnings Based) Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Yunnan Biovalley Pharmaceutical Co's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Yunnan Biovalley Pharmaceutical Co's Margin of Safety % (DCF Earnings Based) falls into.


;
;

Yunnan Biovalley Pharmaceutical Co Margin of Safety % (DCF Earnings Based) Related Terms

Thank you for viewing the detailed overview of Yunnan Biovalley Pharmaceutical Co's Margin of Safety % (DCF Earnings Based) provided by GuruFocus.com. Please click on the following links to see related term pages.

Yunnan Biovalley Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yunnan Biovalley Pharmaceutical Co Ltd (BJSE:833266) » Definitions » Margin of Safety % (DCF Earnings Based)
Comparable Companies
BJSE:430478 SZSE:301075 SHSE:600381 BJSE:833230 SZSE:300391 BJSE:832566 BJSE:873167 SZSE:002750 SHSE:603139 BJSE:836433 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
N/A
Address
No. 999 Biological Valley Street, Majinpu New District, High-tech Zone, Yunnan Province, Kunming City, CHN, 650500
Website
http://ynswgen.biovalley.cn
Yunnan Biovalley Pharmaceutical Co Ltd engages in research and development, production, and marketing of pharmaceuticals and health care based on herbal medicines. The products on the market include breviscapine injection, breviscapine Shengmai capsules, breviscapine tablets, breviscapine dripping pills, Erigeron Capsules, Erigeron Soft Capsules.

Yunnan Biovalley Pharmaceutical Co Headlines

No Headlines